New targets and inhibitors of HBV replication to combat drug resistance

J Clin Virol. 2005 Dec:34 Suppl 1:S147-50. doi: 10.1016/s1386-6532(05)80026-5.

Abstract

All the approved chemotherapeutic drugs for the treatment of HBV hepatitis are nucleoside analogs targeting on HBV DNA polymerase. Drugs targeting on other viral unique targets are needed. A new class of chemicals with novel action against HBV replication was discovered. A brief description of their mode of action is given.

MeSH terms

  • Antiviral Agents* / chemical synthesis
  • Antiviral Agents* / pharmacology
  • DNA, Viral / biosynthesis
  • Drug Design*
  • Hepatitis B virus / drug effects*
  • Hepatitis B virus / genetics
  • Hepatitis B virus / metabolism
  • Lignans
  • Microbial Sensitivity Tests
  • Nucleic Acid Synthesis Inhibitors
  • Virus Replication / drug effects*
  • Xanthines / pharmacology

Substances

  • Antiviral Agents
  • DNA, Viral
  • Lignans
  • Nucleic Acid Synthesis Inhibitors
  • Xanthines
  • helioxanthin